Non-alcoholic fatty liver disease (NAFLD)–pathogenesis, classification, and effect on drug metabolizing enzymes and transporters

E Cobbina, F Akhlaghi - Drug metabolism reviews, 2017 - Taylor & Francis
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver disorders. It is defined by the
presence of steatosis in more than 5% of hepatocytes with little or no alcohol consumption …

[HTML][HTML] Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron

GC Bell, KE Caudle, M Whirl-Carrillo… - Clinical …, 2017 - ncbi.nlm.nih.gov
hydroxytryptamine type 3 (5-HT 3) receptor antagonists are used in the prevention of
chemotherapy-induced, radiation-induced and postoperative nausea and vomiting. CYP2D6 …

Analgesia and opioids: a pharmacogenetics shortlist for implementation in clinical practice

M Matic, SN de Wildt, D Tibboel… - Clinical …, 2017 - academic.oup.com
BACKGROUND The use of opioids to alleviate pain is complicated by the risk of severe
adverse events and the large variability in dose requirements. Pharmacogenetics (PGx) …

Clinical pharmacogenetics of cytochrome P450-associated drugs in children

I Aka, CJ Bernal, R Carroll, A Maxwell-Horn… - Journal of personalized …, 2017 - mdpi.com
Cytochrome P450 (CYP) enzymes are commonly involved in drug metabolism, and genetic
variation in the genes encoding CYPs are associated with variable drug response. While …

Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous …

N Kleiber, RAA Mathôt, MJ Ahsman… - British journal of …, 2017 - Wiley Online Library
Aims Clonidine is used for sedation in the paediatric intensive care unit. Extracorporeal
membrane oxygenation (ECMO) provides temporary support if respiratory and cardiac …

In vitro Phase I- and Phase II-Drug Metabolism in The Liver of Juvenile and Adult Göttingen Minipigs

E Van Peer, F Jacobs, J Snoeys, J Van Houdt… - Pharmaceutical …, 2017 - Springer
Purpose In view of pediatric drug development, juvenile animal studies are gaining
importance. However, data on drug metabolizing capacities of juvenile animals are scarce …

Developmental changes in drug-metabolizing enzyme expression during metamorphosis of Xenopus tropicalis

J Mori, S Sanoh, K Kashiwagi, H Hanada… - The Journal of …, 2017 - jstage.jst.go.jp
A large number of chemicals are routinely detected in aquatic environments, and these
chemicals may adversely affect aquatic organisms. Accurate risk assessment requires …

[图书][B] Age-associated expression patterns of OATP 1B1 and OATP 1B3 and their effect on the disposition of fexofenadine

MM Thomson - 2017 - search.proquest.com
The developmental protein expression pattern of the closely related hepatic uptake
transporters, OATP1B1 and OATP1B3, was examined in human liver tissue samples …

Paving ways for personalizing drug therapy during pregnancy: A focus on the risk of drug teratogenicity

N Daud - 2017 - research.rug.nl
Medication use during pregnancy is very common, but can potentially harm the unborn child.
Many studies have evaluated the safety of certain medications, but data are still lacking. The …

[PDF][PDF] Paving ways for personalizing drug therapy during pregnancy

N Daud - 2017 - research.rug.nl
Paving ways for personalizing drug therapy during pregnancy University of Groningen Paving
ways for personalizing drug therapy during pregnancy Daud, Nur IMPORTANT NOTE: You are …